News and Analysis

Prof. Pekka Puska's answers to PHM's questions

Prof. Puska's answers to the inquiries from the People’s Health Movement to the Candidates for the position of WHO’s Director General.

Author/Source: 
PHM Global Secretariat
Type: 
News and Analysis: 

Dr. Margaret Chan's answers to PHM's questions

PHM Global Secretariat
11 October 2006

Dr. Margaret Chan's answers to the inquiries from the People’s Health Movement to the Candidates for the position of WHO’s Director General.

Author/Source: 
PHM Global Secretariat
Type: 
News and Analysis: 

Dr. Julio Frenk's answers to PHM's questions

Dr. Julio Frenk's answers to the inquiries from the People’s Health Movement to the Candidates for the position of WHO’s Director General.

Author/Source: 
PHM Global Secretariat
Type: 
News and Analysis: 

First meeting of PHM Aotearoa/ New Zealand

A meeting was held on Tuesday, 3rd October, 2006 in Auckland to discuss setting up a PHM Aotearoa/ New Zealand circle.

Author/Source: 
PHM Aotearoa/New Zealand
News and Analysis: 

First meeting of PHM Aotearoa/ New Zealand

A meeting was held on Tuesday, 3rd October, 2006 in Auckland to discuss setting up a PHM Aotearoa/ New Zealand circle.

Author/Source: 
PHM Aotearoa/New Zealand
News and Analysis: 

Initial Responses from Candidates

These are the initial responses from the candidates for the position of WHO’s Director General to the questions the People's Health Movement sent them.

Author/Source: 
PHM Global Secretariat
Type: 
News and Analysis: 

Inquiries from the People’s Health Movement to the Candidates for the position of WHO’s Director General

PHM Global Secretariat
30 September 2006

 

The following questions have been sent to the candidates for the position of WHO’s Director General by the People's Health Movement.

 

Author/Source: 
PHM Global Secretariat
Type: 
News and Analysis: 

A new WHO Director General is to be shortly elected

The global and supranational determinants of health have become increasingly important. This makes the performance of global public health institutions of greater significance.

Author/Source: 
PHM Global Secretariat
Type: 
News and Analysis: 

Novartis Challenges Indian safeguards

A patent for the cancer drug Gleevec was rejected based on the grounds that it was merely a new form of an old drug, which according to the Indian law, cannot be patented. But Novartis is now challenging the patent rejection, and the Indian law that protects thousands of cancer sufferers and their families.

Author/Source: 
MSF & Lawyers Collective, India
News and Analysis: 

Novartis Challenges Indian safeguards

A patent for the cancer drug Gleevec was rejected based on the grounds that it was merely a new form of an old drug, which according to the Indian law, cannot be patented. But Novartis is now challenging the patent rejection, and the Indian law that protects thousands of cancer sufferers and their families.

Author/Source: 
MSF & Lawyers Collective, India
News and Analysis: 

Pages